Return On Equity of ACRO BIOMEDICAL CO., LTD. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ACRO BIOMEDICAL CO., LTD. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • ACRO BIOMEDICAL CO., LTD. Return On Equity for the quarter ending 30 Sep 2025 was 46%, a 149% increase year-over-year.
  • ACRO BIOMEDICAL CO., LTD. annual Return On Equity for 2024 was 15%.
  • ACRO BIOMEDICAL CO., LTD. annual Return On Equity for 2023 was -13874%, a 380% decline from 2022.
  • ACRO BIOMEDICAL CO., LTD. annual Return On Equity for 2022 was -2890%, a 133% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ACRO BIOMEDICAL CO., LTD. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 46% +27% +149% 01 Jul 2025 30 Sep 2025
Q2 2025 16% -611% -98% 01 Apr 2025 30 Jun 2025
Q1 2025 14% -4525% -100% 01 Jan 2025 31 Mar 2025
Q4 2024 15% +13889% 01 Oct 2024 31 Dec 2024
Q3 2024 18% +5122% 01 Jul 2024 30 Sep 2024
Q2 2024 626% +4130% 01 Apr 2024 30 Jun 2024
Q1 2024 4539% +7786% 01 Jan 2024 31 Mar 2024
Q4 2023 -13874% -10984% -380% 01 Oct 2023 31 Dec 2023
Q3 2023 -5103% -2420% -90% 01 Jul 2023 30 Sep 2023
Q2 2023 -3504% -1073% -44% 01 Apr 2023 30 Jun 2023
Q1 2023 -3247% -1393% -75% 01 Jan 2023 31 Mar 2023
Q4 2022 -2890% -1649% -133% 01 Oct 2022 31 Dec 2022
Q3 2022 -2683% -2064% -333% 01 Jul 2022 30 Sep 2022
Q2 2022 -2431% -2285% -1559% 01 Apr 2022 30 Jun 2022
Q1 2022 -1854% -1818% -5068% 01 Jan 2022 31 Mar 2022
Q4 2021 -1241% -1226% -8164% 01 Oct 2021 31 Dec 2021
Q3 2021 -619% -603% -3714% 01 Jul 2021 30 Sep 2021
Q2 2021 -147% -131% -823% 01 Apr 2021 30 Jun 2021
Q1 2021 -36% -22% -160% 01 Jan 2021 31 Mar 2021
Q4 2020 -15% +26% +63% 01 Oct 2020 31 Dec 2020
Q3 2020 -16% +21% +56% 01 Jul 2020 30 Sep 2020
Q2 2020 -16% -3% -22% 01 Apr 2020 30 Jun 2020
Q1 2020 -14% -16% -673% 01 Jan 2020 31 Mar 2020
Q4 2019 -41% -69% -249% 01 Oct 2019 31 Dec 2019
Q3 2019 -37% -88% -172% 01 Jul 2019 30 Sep 2019
Q2 2019 -13% -61% -127% 01 Apr 2019 30 Jun 2019
Q1 2019 2% -38% -94% 01 Jan 2019 31 Mar 2019
Q4 2018 27% -5% -15% 01 Oct 2018 31 Dec 2018
Q3 2018 51% +53% 01 Jul 2018 30 Sep 2018
Q2 2018 48% -187% -80% 01 Apr 2018 30 Jun 2018
Q1 2018 41% -302% -88% 01 Jan 2018 31 Mar 2018
Q4 2017 32% -366% -92% 01 Oct 2017 31 Dec 2017
Q3 2017 -2% 01 Jul 2017 30 Sep 2017
Q2 2017 235% 01 Apr 2017 30 Jun 2017
Q1 2017 343% 01 Jan 2017 31 Mar 2017
Q4 2016 398% 01 Oct 2016 31 Dec 2016

ACRO BIOMEDICAL CO., LTD. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 15% +13889% 01 Jan 2024 31 Dec 2024
2023 -13874% -10984% -380% 01 Jan 2023 31 Dec 2023
2022 -2890% -1649% -133% 01 Jan 2022 31 Dec 2022
2021 -1241% -1226% -8164% 01 Jan 2021 31 Dec 2021
2020 -15% +26% +63% 01 Jan 2020 31 Dec 2020
2019 -41% -92% -180% 01 Jan 2019 31 Dec 2019
2018 51% +53% 01 Oct 2017 30 Sep 2018
2017 -2% 01 Oct 2016 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.